2021
DOI: 10.1016/j.media.2021.102179
|View full text |Cite
|
Sign up to set email alerts
|

Quantifying Parkinson’s disease motor severity under uncertainty using MDS-UPDRS videos

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
52
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 58 publications
(53 citation statements)
references
References 40 publications
0
52
0
1
Order By: Relevance
“…In addition, the computation of the MC method [1] takes a long time due to its high complexity. (2) In about 75% of the cases, the shared backbone (F 1 = F 2 ) for feature extraction gives higher accuracies than the independent backbone (F 1 = F 2 ). (3) When using the CNN for the relation regression, models using SFCN as the backbone provides lower MAEs than models using mSFCN as the backbone.…”
Section: B Accuracy Of Relation-based Brain Age Estimationmentioning
confidence: 99%
See 3 more Smart Citations
“…In addition, the computation of the MC method [1] takes a long time due to its high complexity. (2) In about 75% of the cases, the shared backbone (F 1 = F 2 ) for feature extraction gives higher accuracies than the independent backbone (F 1 = F 2 ). (3) When using the CNN for the relation regression, models using SFCN as the backbone provides lower MAEs than models using mSFCN as the backbone.…”
Section: B Accuracy Of Relation-based Brain Age Estimationmentioning
confidence: 99%
“…Regression aims to estimate continuous values (or ordinal outcomes [1]) from the input data using machine learning models. It has many applications such as severity scores [2], [3], brain age estimation [4], [5] and fluid intelligence prediction [6]. Deep convolutional neural networks (CNNs) can transform the raw input image data into target variables by training on a large-scale dataset [7].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…This score is worldwide-used for patient follow-up in outpatient clinic but also in clinical research and more specifically in therapeutic trials. However, the semi-quantitative assessment of parkinsonian symptoms by the MDS-UPDRS III score suffers from a certain subjectivity and the reproducibility of the measurements arising from assessors is questionable especially in case of nonparkinsonian expertise [7][8][9][10][11][12][13]. This may contribute to the difficulty in the follow-up of PD patients and also to induce some biases in clinical research due to the multiplicity of assessors and clinical centers, and variability across longitudinal iterative visits.…”
Section: Introductionmentioning
confidence: 99%